Free Trial
→ Watch This Robotics Demo Before July 23rd (From Brownstone Research) (Ad) Buy RNR Stock  Free RNR Stock Alerts

RenaissanceRe (RNR) Financials

RenaissanceRe logo
$245.22 +5.53 (+2.31%)
Closing price 03:59 PM Eastern
Extended Trading
$245.34 +0.12 (+0.05%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for RenaissanceRe

Annual Income Statements for RenaissanceRe

This table shows RenaissanceRe's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders		 1,835 2,526 -1,097 -73 731 712 197 -245 481 409
Consolidated Net Income / (Loss)		 2,961 3,620 -1,160 -103 993 950 269 -355 630 542
Net Income / (Loss) Continuing Operations		 2,961 3,620 -1,160 -103 993 536 269 -355 630 542
Total Pre-Tax Income 		2,993 3,110 -1,219 -114 996 553 263 -328 630 496
Total Revenue		 11,601 9,061 5,012 5,230 5,122 3,729 2,028 2,059 1,686 1,479
Net Interest Income / (Expense)		 -94 -73 -48 -48 -50 -58 -47 -44 -42 -36
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 94 73 48 48 50 58 47 44 42 36
Long-Term Debt Interest Expense		 94 73 48 48 50 58 47 44 42 36
Total Non-Interest Income		 11,695 9,135 5,060 5,278 5,172 3,788 2,075 2,104 1,728 1,515
Other Service Charges		 1.93 -6.15 13 11 0.21 4.95 5.97 9.42 14 13
Net Realized & Unrealized Capital Gains on Investments		 1,597 1,670 -1,286 73 1,220 444 93 377 310 101
Premiums Earned		 10,096 7,471 6,334 5,194 3,952 3,338 1,976 1,718 1,403 1,401
Total Non-Interest Expense		 8,608 5,951 6,231 5,344 4,126 3,176 1,765 2,388 1,055 982
Property & Liability Insurance Claims		 5,333 3,574 4,339 3,876 2,925 2,097 1,120 1,861 531 448
Other Operating Expenses		 135 128 47 41 97 94 34 19 235 296
Amortization Expense		 2,644 1,875 1,569 1,215 898 762 433 347 289 239
Other Special Charges		 497 375 277 212 207 223 178 161 - -
Income Tax Expense		 33 -510 -59 -11 2.86 17 -6.30 26 0.34 -46
Preferred Stock Dividends Declared		 35 35 35 33 31 37 30 22 22 22
Net Income / (Loss) Attributable to Noncontrolling Interest		 1,090 1,059 -99 -63 231 201 42 -132 127 111
Basic Earnings per Share		 $35.31 $52.40 ($25.50) ($1.57) $15.34 $16.32 $4.91 ($6.15) $11.50 $9.36
Weighted Average Basic Shares Outstanding		 49.25M 52.69M 43.72M 43.98M 50.71M 44.15M 39.73M 39.85M 41.31M 43.16M
Diluted Earnings per Share		 $35.21 $52.27 ($25.50) ($1.57) $15.31 $16.29 $4.91 ($6.15) $11.43 $9.28
Weighted Average Diluted Shares Outstanding		 49.25M 52.69M 43.72M 43.98M 50.71M 44.15M 39.73M 39.85M 41.31M 43.16M
Weighted Average Basic & Diluted Shares Outstanding		 49.25M 52.69M 43.72M 43.98M 50.71M 44.15M 39.73M 39.85M 41.31M 43.16M
Cash Dividends to Common per Share		 $1.56 - - - - - - $1.28 $1.24 $1.20

Quarterly Income Statements for RenaissanceRe

This table shows RenaissanceRe's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 161 -199 1,174 495 365 1,577 194 191 564 448 -825
Consolidated Net Income / (Loss)		 -25 -19 1,633 729 618 1,989 417 375 840 693 -1,189
Net Income / (Loss) Continuing Operations		 -25 -19 1,633 729 618 1,989 417 375 840 693 -1,189
Total Pre-Tax Income 		-71 -83 1,735 708 634 1,434 426 381 869 699 -1,186
Total Revenue		 3,443 2,223 3,974 2,829 2,576 3,179 1,836 1,853 2,193 2,018 1,274
Net Interest Income / (Expense)		 -27 -71 0.00 0.00 -23 -61 0.00 0.00 -12 -12 -12
Total Interest Income		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense		 27 71 0.00 0.00 23 61 0.00 0.00 12 12 12
Long-Term Debt Interest Expense		 27 - - - 23 - - - 12 12 12
Total Non-Interest Income		 3,470 2,293 3,974 2,829 2,599 3,240 1,836 1,853 2,205 2,031 1,287
Other Service Charges		 0.91 1.13 0.68 0.17 -0.05 0.14 -5.87 3.88 -4.31 7.69 2.83
Net Realized & Unrealized Capital Gains on Investments		 749 -235 1,390 287 156 991 86 64 529 399 -483
Premiums Earned		 2,721 2,528 2,583 2,541 2,444 2,249 1,756 1,785 1,681 1,624 1,767
Total Non-Interest Expense		 3,514 2,306 2,239 2,121 1,942 1,745 1,410 1,473 1,324 1,319 2,461
Property & Liability Insurance Claims		 2,744 1,484 1,374 1,310 1,166 980 862 931 801 823 1,968
Other Operating Expenses		 23 -13 50 59 39 36 40 38 13 12 10
Amortization Expense		 647 678 690 644 631 594 426 423 432 413 418
Other Special Charges		 100 157 125 108 106 134 83 80 77 72 65
Income Tax Expense		 -46 -64 102 -21 15 -554 9.30 5.94 29 5.41 2.81
Preferred Stock Dividends Declared		 8.84 8.84 8.84 8.84 8.84 8.84 8.84 8.84 8.84 8.84 8.84
Net Income / (Loss) Attributable to Noncontrolling Interest		 -195 170 450 225 245 403 214 175 267 236 -372
Basic Earnings per Share		 $3.29 ($3.77) $22.68 $9.44 $6.96 $31.54 $3.81 $4.10 $12.95 $10.40 ($19.27)
Weighted Average Basic Shares Outstanding		 48.65M 49.25M 51.94M 52.16M 52.88M 52.69M 51.17M 51.18M 43.93M 43.72M 43.70M
Diluted Earnings per Share		 $3.27 ($3.76) $22.62 $9.41 $6.94 $31.47 $3.80 $4.09 $12.91 $10.40 ($19.27)
Weighted Average Diluted Shares Outstanding		 48.65M 49.25M 51.94M 52.16M 52.88M 52.69M 51.17M 51.18M 43.93M 43.72M 43.70M
Weighted Average Basic & Diluted Shares Outstanding		 48.65M 49.25M 51.94M 52.16M 52.88M 52.69M 51.17M 51.18M 43.93M 43.72M 43.70M
Cash Dividends to Common per Share		 $0.40 - $0.39 - - - - $0.38 $0.38 - $0.37

Annual Cash Flow Statements for RenaissanceRe

This table details how cash moves in and out of RenaissanceRe's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents		 -201 683 -665 122 358 271 -254 940 -86 -19
Net Cash From Operating Activities		 4,165 1,912 1,604 1,235 1,993 2,137 1,222 1,026 485 425
Net Cash From Continuing Operating Activities		 4,165 1,912 1,604 1,235 1,993 2,137 1,222 1,026 322 512
Net Income / (Loss) Continuing Operations		 2,961 3,620 -1,160 -103 993 950 269 -355 630 542
Consolidated Net Income / (Loss)		 2,961 3,620 -1,160 -103 993 950 269 -355 630 542
Depreciation Expense		 258 -135 -27 -21 17 -59 0.12 31 29 18
Non-Cash Adjustments to Reconcile Net Income		 -20 -490 1,646 219 -789 -415 230 -154 -147 73
Changes in Operating Assets and Liabilities, net		 966 -1,083 1,145 1,140 1,772 1,661 723 1,503 -27 -208
Net Cash From Investing Activities		 -3,061 -3,823 -3,016 -816 -2,305 -2,989 -2,537 -122 -165 -339
Net Cash From Continuing Investing Activities		 -3,061 -3,823 -3,016 -816 -2,305 -2,989 -2,537 -122 -165 -339
Purchase of Investment Securities		 -59,478 -67,833 -52,789 -16,575 -17,638 -20,306 -14,147 -10,113 -8,470 -10,519
Sale and/or Maturity of Investments		 56,417 64,011 49,773 15,552 15,196 17,325 11,611 9,875 8,121 10,180
Net Cash From Financing Activities		 -1,288 2,589 725 -302 665 1,120 1,066 29 -401 -94
Net Cash From Continuing Financing Activities		 -1,288 2,589 725 -302 665 1,120 1,066 29 -401 -94
Issuance of Debt		 75 816 0.00 30 0.00 396 0.00 296 0.00 446
Issuance of Common Equity		 0.00 1,352 0.00 0.00 1,096 0.00 250 0.00 0.00 -
Repayment of Debt		 -150 -30 0.00 0.00 -250 0.00 0.00 -250 0.00 -
Repurchase of Common Equity		 -667 0.00 -167 -1,028 -63 0.00 0.00 -189 -309 -260
Payment of Dividends		 -116 -110 -100 -101 -99 -96 -83 -74 -74 -76
Other Financing Activities, Net		 -429 562 992 582 107 820 658 245 -18 -203
Effect of Exchange Rate Changes		 -17 5.54 22 6.15 4.49 2.48 -5.10 8.22 -4.64 -11
Cash Interest Paid		 88 74 46 21 49 53 46 44 54 41
Cash Income Taxes Paid		 100 27 3.13 -4.26 5.67 9.75 0.34 0.34 -1.12 10

Quarterly Cash Flow Statements for RenaissanceRe

This table details how cash moves in and out of RenaissanceRe's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 -44 104 -54 20 -271 682 252 -120 -131 -9.90 -194
Net Cash From Operating Activities		 158 779 1,490 1,212 683 512 772 191 436 733 601
Net Cash From Continuing Operating Activities		 158 779 1,490 1,212 683 512 772 191 436 733 601
Net Income / (Loss) Continuing Operations		 -25 -19 1,633 729 618 1,989 417 375 840 693 -1,189
Consolidated Net Income / (Loss)		 -25 -19 1,633 729 618 1,989 417 375 840 693 -1,189
Depreciation Expense		 3.74 6.85 226 9.96 16 -14 -48 -40 -33 -26 -11
Non-Cash Adjustments to Reconcile Net Income		 -190 519 -843 139 165 -637 253 155 -262 -178 589
Changes in Operating Assets and Liabilities, net		 369 272 475 335 -116 -825 150 -299 -110 243 1,212
Net Cash From Investing Activities		 -499 -280 -1,497 -979 -304 -314 -328 -2,497 -685 -1,234 -826
Net Cash From Continuing Investing Activities		 -499 -280 -1,497 -979 -304 -314 -328 -2,497 -685 -1,234 -826
Purchase of Investment Securities		 -14,228 -12,370 -13,906 -18,292 -14,909 -22,432 -15,850 -16,920 -12,631 -32,839 -8,749
Sale and/or Maturity of Investments		 13,729 12,090 12,410 17,313 14,605 22,118 15,522 14,424 11,947 31,267 7,973
Net Cash From Financing Activities		 290 -376 -58 -209 -645 485 -198 2,186 116 500 19
Net Cash From Continuing Financing Activities		 290 -376 -58 -209 -645 485 -198 2,186 116 500 19
Issuance of Debt		 866 - - - - 75 -1.02 - - - -
Repayment of Debt		 0.00 -50 -25 - -75 - - - -30 - -
Repurchase of Common Equity		 -358 -452 -107 - - - - - - - -25
Payment of Dividends		 -28 -29 -29 -29 -29 -29 -28 -28 -26 -25 -25
Other Financing Activities, Net		 -190 154 103 -146 -540 438 -168 119 172 525 69
Effect of Exchange Rate Changes		 7.50 -19 10 -3.57 -5.21 -1.86 5.01 0.32 2.07 -9.31 13

Annual Balance Sheets for RenaissanceRe

This table presents RenaissanceRe's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets		 50,708 49,007 36,553 33,960 30,821 26,330 18,676 15,226 12,352 11,555
Cash and Due from Banks		 1,677 1,878 1,194 1,859 1,737 1,379 1,108 1,362 421 507
Trading Account Securities		 28,108 24,612 17,551 16,144 15,564 12,803 9,299 7,917 7,399 7,309
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 238 206 122 56 67 72 51 42 38 40
Unearned Premiums Asset		 8,179 13,550 10,872 8,905 6,644 6,159 2,153 1,838 1,429 1,009
Deferred Acquisition Cost		 1,552 1,751 1,172 849 634 664 477 427 335 199
Intangible Assets		 704 775 238 243 250 262 237 243 251 265
Other Assets		 10,250 6,235 5,405 5,903 5,925 4,991 5,350 3,398 2,479 2,226
Total Liabilities & Shareholders' Equity		 50,708 49,007 36,553 33,960 30,821 26,330 18,676 15,226 12,352 11,555
Total Liabilities		 33,156 33,451 26,692 23,781 19,872 17,287 11,579 9,538 6,310 5,777
Short-Term Debt		 151 662 494 1,171 1,133 225 380 209 306 391
Long-Term Debt		 1,887 1,959 1,170 1,168 1,136 1,384 991 990 949 960
Claims and Claim Expense		 21,303 20,487 15,893 13,295 10,381 9,384 6,076 5,080 2,848 2,767
Unearned Premiums Liability		 5,950 6,136 4,559 3,531 2,764 2,531 1,716 1,478 1,232 889
Other Long-Term Liabilities		 3,864 4,208 4,576 4,616 4,458 3,763 2,416 1,782 976 769
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 6,978 6,101 4,535 3,554 3,388 3,071 2,052 1,297 1,176 1,046
Total Equity & Noncontrolling Interests		 10,574 9,455 5,325 6,624 7,560 5,971 5,045 4,391 4,867 4,732
Total Preferred & Common Equity		 10,574 9,455 5,325 6,624 7,560 5,971 5,045 4,391 4,867 4,732
Preferred Stock		 750 750 750 750 525 650 650 400 400 400
Total Common Equity		 9,824 8,705 4,575 5,874 7,035 5,321 4,395 3,991 4,467 4,332
Common Stock		 1,563 2,197 519 653 1,674 612 338 77 258 551
Retained Earnings		 8,276 6,522 4,071 5,233 5,374 4,711 4,058 3,914 4,208 3,779
Accumulated Other Comprehensive Income / (Loss)		 -15 -14 -15 -11 -13 -1.94 -1.43 0.22 1.13 2.11

Quarterly Balance Sheets for RenaissanceRe

This table presents RenaissanceRe's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets		 53,633 52,756 51,568 50,944 40,843 41,400 38,270 35,936
Cash and Due from Banks		 1,633 1,573 1,627 1,607 1,196 944 1,064 1,204
Trading Account Securities		 28,539 28,731 26,168 24,877 19,352 19,070 18,032 15,957
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 217 223 226 197 154 148 122 85
Unearned Premiums Asset		 14,230 9,424 15,081 9,714 6,958 12,367 11,771 11,682
Deferred Acquisition Cost		 1,685 1,719 1,816 1,822 1,267 1,301 1,242 1,181
Intangible Assets		 686 717 737 759 234 235 237 239
Other Assets		 6,644 10,369 5,913 11,968 11,683 7,242 5,802 5,587
Total Liabilities & Shareholders' Equity		 53,633 52,756 51,568 50,944 40,843 41,400 38,270 35,936
Total Liabilities		 36,595 34,653 35,053 34,854 27,592 28,321 27,047 26,879
Short-Term Debt		 552 607 778 1,428 812 548 389 590
Long-Term Debt		 2,754 1,936 1,960 1,884 1,883 1,882 1,141 1,170
Claims and Claim Expense		 22,857 21,221 20,741 20,370 15,955 16,138 15,997 15,663
Unearned Premiums Liability		 6,999 7,041 7,697 7,248 5,222 5,717 5,251 5,046
Other Long-Term Liabilities		 3,433 3,848 3,877 3,924 3,720 4,035 4,270 4,410
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 6,690 6,861 6,335 6,298 5,662 5,676 5,357 4,175
Total Equity & Noncontrolling Interests		 10,349 11,243 10,179 9,793 7,589 7,403 5,866 4,882
Total Preferred & Common Equity		 10,349 11,243 10,179 9,793 7,589 7,403 5,866 4,882
Preferred Stock		 750 750 750 750 750 750 750 750
Total Common Equity		 9,599 10,493 9,429 9,043 6,839 6,653 5,116 4,132
Common Stock		 1,196 2,011 2,101 2,190 1,888 1,876 512 509
Retained Earnings		 8,418 8,495 7,341 6,866 4,965 4,790 4,619 3,639
Accumulated Other Comprehensive Income / (Loss)		 -15 -13 -13 -14 -15 -14 -15 -17

Annual Metrics And Ratios for RenaissanceRe

This table displays calculated financial ratios and metrics derived from RenaissanceRe's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 28.03% 80.79% -4.17% 2.11% 37.33% 83.91% -1.54% 22.17% 13.99% 19.00%
EBITDA Growth		 9.29% 338.83% -822.14% -113.34% 104.80% 88.18% 188.48% -145.01% 28.21% -29.96%
EBIT Growth		 -3.76% 355.17% -968.14% -111.46% 79.97% 110.72% 180.02% -152.06% 27.00% -27.73%
NOPAT Growth		 -18.22% 524.31% -968.14% -108.04% 85.22% 99.38% 217.06% -136.46% 16.19% -20.99%
Net Income Growth		 -18.22% 412.13% -1,021.25% -110.42% 4.50% 253.37% 175.82% -156.29% 16.19% -20.99%
EPS Growth		 -32.64% 304.98% -1,524.20% -110.25% -6.02% 231.77% 179.84% -153.81% 23.17% -26.35%
Operating Cash Flow Growth		 117.87% 19.20% 29.87% -38.03% -6.76% 74.94% 19.10% 111.60% 14.07% -35.67%
Free Cash Flow Firm Growth		 151.05% -2,277.64% -77.56% 139.45% 4.58% -25.48% -827.20% -61.04% 140.74% -266.55%
Invested Capital Growth		 7.77% 57.71% -7.93% -5.30% 24.08% 25.79% 22.97% -5.62% 2.34% 30.83%
Revenue Q/Q Growth		 -7.62% 14.70% 24.36% -14.81% 32.96% 3.88% 2.88% 7.08% -1.37% 3.68%
EBITDA Q/Q Growth		 -31.52% 33.56% 36.51% -120.15% 738.63% -33.16% -45.54% -14.87% -7.59% -14.86%
EBIT Q/Q Growth		 -33.64% 30.98% 37.70% -117.08% 897.34% -30.63% -40.16% -13.93% -7.45% -14.86%
NOPAT Q/Q Growth		 -40.41% 55.71% 37.70% -111.29% 1,235.78% -31.78% -31.94% -13.93% -5.21% -14.87%
Net Income Q/Q Growth		 -40.41% 55.71% 25.88% 48.30% 17.97% 20.91% -31.94% -33.53% -5.21% -14.87%
EPS Q/Q Growth		 -50.01% 67.53% 18.27% 40.53% 23.87% 20.67% -31.14% -34.87% -1.64% -21.22%
Operating Cash Flow Q/Q Growth		 6.83% -10.35% 23.04% -15.70% -9.53% 33.77% -6.93% 45.27% -24.63% -1.03%
Free Cash Flow Firm Q/Q Growth		 478.48% -8.11% 213.84% -71.22% 44.46% 18.26% -70.93% -49.37% -22.01% 12.05%
Invested Capital Q/Q Growth		 -5.12% 13.99% 6.55% 3.76% -2.18% -1.08% 6.29% 1.22% -0.89% -2.21%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 28.03% 32.83% -24.86% -2.58% 19.77% 13.26% 12.96% -14.42% 39.13% 34.79%
EBIT Margin		 25.80% 34.32% -24.32% -2.18% 19.44% 14.84% 12.95% -15.94% 37.40% 33.57%
Profit (Net Income) Margin		 25.52% 39.95% -23.14% -1.98% 19.39% 25.48% 13.26% -17.22% 37.38% 36.67%
Tax Burden Percent		 98.91% 116.40% 95.16% 90.65% 99.71% 171.72% 102.40% 108.07% 99.95% 109.24%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 1.09% -16.40% 0.00% 0.00% 0.29% 3.11% -2.40% 0.00% 0.05% -9.24%
Return on Invested Capital (ROIC)		 15.68% 24.38% -7.10% -0.62% 8.32% 5.61% 3.50% -3.24% 8.73% 8.62%
ROIC Less NNEP Spread (ROIC-NNEP)		 15.68% 24.38% -22.42% -1.64% 8.32% 33.39% 3.50% -13.43% 8.73% 8.62%
Return on Net Nonoperating Assets (RNNOA)		 2.21% 4.11% -4.48% -0.36% 1.61% 6.17% 0.70% -2.81% 1.93% 1.44%
Return on Equity (ROE)		 17.88% 28.49% -11.58% -0.98% 9.93% 11.78% 4.21% -6.05% 10.66% 10.06%
Cash Return on Invested Capital (CROIC)		 8.19% -20.41% 1.16% 4.82% -13.17% -17.23% -17.10% 2.55% 6.43% -18.09%
Operating Return on Assets (OROA)		 6.00% 7.27% -3.46% -0.35% 3.49% 2.46% 1.55% -2.38% 5.27% 5.02%
Return on Assets (ROA)		 5.94% 8.46% -3.29% -0.32% 3.48% 4.22% 1.59% -2.57% 5.27% 5.49%
Return on Common Equity (ROCE)		 10.01% 14.88% -6.04% -0.60% 6.14% 7.09% 2.76% -4.36% 7.94% 7.28%
Return on Equity Simple (ROE_SIMPLE)		 28.00% 38.29% -21.78% -1.56% 13.14% 15.91% 5.33% -8.08% 12.95% 11.46%
Net Operating Profit after Tax (NOPAT)		 2,961 3,620 -853 -80 993 536 269 -230 630 542
NOPAT Margin		 25.52% 39.95% -17.02% -1.53% 19.39% 14.38% 13.26% -11.15% 37.38% 36.67%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 15.32% 1.02% 0.00% -27.78% 0.00% 10.19% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 74.20% 65.68% 124.32% 102.18% 80.56% 85.16% 87.05% 115.94% 62.60% 66.43%
Earnings before Interest and Taxes (EBIT)		 2,993 3,110 -1,219 -114 996 553 263 -328 630 496
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 3,252 2,975 -1,246 -135 1,013 494 263 -297 660 515
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 1.32 1.14 1.73 1.30 1.16 1.57 1.17 1.19 1.18 1.06
Price to Tangible Book Value (P/TBV)		 1.42 1.26 1.83 1.36 1.20 1.65 1.24 1.27 1.25 1.13
Price to Revenue (P/Rev)		 1.11 1.10 1.58 1.46 1.60 2.23 2.53 2.31 3.11 3.11
Price to Earnings (P/E)		 7.04 3.95 0.00 0.00 11.18 11.70 26.05 0.00 10.92 11.25
Dividend Yield		 0.63% 0.78% 0.81% 0.87% 0.87% 0.72% 1.03% 1.08% 0.97% 1.14%
Earnings Yield		 14.20% 25.34% 0.00% 0.00% 8.95% 8.55% 3.84% 0.00% 9.15% 8.89%
Enterprise Value to Invested Capital (EV/IC)		 1.07 0.97 1.19 0.99 0.95 1.15 0.96 0.91 1.05 0.97
Enterprise Value to Revenue (EV/Rev)		 1.81 1.94 2.73 2.37 2.46 3.29 4.00 3.05 4.54 4.66
Enterprise Value to EBITDA (EV/EBITDA)		 6.46 5.90 0.00 0.00 12.46 24.84 30.85 0.00 11.61 13.39
Enterprise Value to EBIT (EV/EBIT)		 7.02 5.65 0.00 0.00 12.67 22.19 30.86 0.00 12.15 13.88
Enterprise Value to NOPAT (EV/NOPAT)		 7.10 4.85 0.00 0.00 12.71 22.90 30.14 0.00 12.16 12.71
Enterprise Value to Operating Cash Flow (EV/OCF)		 5.05 9.19 8.54 10.05 6.33 5.75 6.63 6.13 15.80 16.21
Enterprise Value to Free Cash Flow (EV/FCFF)		 13.58 0.00 98.38 20.02 0.00 0.00 0.00 34.81 16.52 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.12 0.17 0.17 0.23 0.21 0.18 0.19 0.21 0.21 0.23
Long-Term Debt to Equity		 0.11 0.13 0.12 0.11 0.10 0.15 0.14 0.17 0.16 0.17
Financial Leverage		 0.14 0.17 0.20 0.22 0.19 0.18 0.20 0.21 0.22 0.17
Leverage Ratio		 3.01 3.37 3.52 3.07 2.86 2.79 2.65 2.35 2.02 1.83
Compound Leverage Factor		 3.01 3.37 3.52 3.07 2.86 2.79 2.65 2.35 2.02 1.83
Debt to Total Capital		 10.40% 14.42% 14.44% 18.69% 17.17% 15.11% 16.20% 17.40% 17.19% 18.96%
Short-Term Debt to Total Capital		 0.77% 3.64% 4.28% 9.35% 8.57% 2.11% 4.49% 3.03% 4.19% 5.49%
Long-Term Debt to Total Capital		 9.63% 10.78% 10.16% 9.33% 8.60% 12.99% 11.70% 14.37% 13.00% 13.47%
Preferred Equity to Total Capital		 3.83% 4.13% 6.51% 5.99% 3.97% 6.10% 7.68% 5.81% 5.48% 5.61%
Noncontrolling Interests to Total Capital		 35.62% 33.57% 39.35% 28.39% 25.64% 28.83% 24.23% 18.83% 16.11% 14.67%
Common Equity to Total Capital		 50.15% 47.89% 39.70% 46.93% 53.23% 49.96% 51.90% 57.96% 61.21% 60.76%
Debt to EBITDA		 0.63 0.88 -1.34 -17.31 2.24 3.26 5.22 -4.04 1.90 2.63
Net Debt to EBITDA		 0.11 0.25 -0.38 -3.55 0.53 0.47 1.00 0.55 1.26 1.64
Long-Term Debt to EBITDA		 0.58 0.66 -0.94 -8.65 1.12 2.80 3.77 -3.33 1.44 1.87
Debt to NOPAT		 0.69 0.72 -1.95 -29.28 2.28 3.00 5.10 -5.22 1.99 2.49
Net Debt to NOPAT		 0.12 0.21 -0.55 -6.01 0.54 0.43 0.98 0.71 1.32 1.56
Long-Term Debt to NOPAT		 0.64 0.54 -1.37 -14.63 1.14 2.58 3.69 -4.31 1.51 1.77
Noncontrolling Interest Sharing Ratio		 44.03% 47.75% 47.85% 38.90% 38.19% 39.80% 34.40% 27.90% 25.56% 27.63%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 1,547 -3,031 139 620 -1,572 -1,648 -1,313 181 464 -1,138
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 16.50 -41.42 2.88 13.05 -31.16 -28.23 -27.90 4.09 11.00 -31.37
Operating Cash Flow to Interest Expense		 44.42 26.12 33.18 25.98 39.50 36.62 25.96 23.21 11.50 11.72
Operating Cash Flow Less CapEx to Interest Expense		 44.42 26.12 33.18 25.98 39.50 36.62 25.96 23.21 11.50 11.72
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.23 0.21 0.14 0.16 0.18 0.17 0.12 0.15 0.14 0.15
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 19,589 18,176 11,525 12,517 13,217 10,652 8,468 6,886 7,297 7,130
Invested Capital Turnover		 0.61 0.61 0.42 0.41 0.43 0.39 0.26 0.29 0.23 0.24
Increase / (Decrease) in Invested Capital		 1,413 6,651 -992 -700 2,565 2,184 1,582 -410 167 1,680
Enterprise Value (EV)		 21,012 17,559 13,693 12,415 12,620 12,279 8,105 6,285 7,658 6,891
Market Capitalization		 12,923 9,966 7,938 7,631 8,175 8,328 5,140 4,751 5,250 4,600
Book Value per Share		 $189.14 $170.11 $104.69 $127.65 $138.46 $120.52 $109.15 $99.71 $108.53 $98.80
Tangible Book Value per Share		 $175.59 $154.96 $99.25 $122.36 $133.55 $114.58 $103.26 $93.64 $102.43 $92.75
Total Capital		 19,589 18,176 11,525 12,517 13,217 10,652 8,468 6,886 7,297 7,130
Total Debt		 2,037 2,620 1,664 2,339 2,269 1,609 1,371 1,198 1,254 1,352
Total Long-Term Debt		 1,887 1,959 1,170 1,168 1,136 1,384 991 990 949 960
Net Debt		 361 743 470 480 532 230 264 -163 833 845
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 0.00 0.00 307 24 0.00 -414 0.00 125 0.00 0.00
Net Nonoperating Obligations (NNO)		 2,037 2,620 1,664 2,339 2,269 1,609 1,371 1,198 1,254 1,352
Total Depreciation and Amortization (D&A)		 258 -135 -27 -21 17 -59 0.12 31 29 18
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $35.31 $52.40 ($25.50) ($1.57) $15.34 $16.32 $4.91 ($6.15) $11.50 $9.36
Adjusted Weighted Average Basic Shares Outstanding		 49.25M 52.69M 43.72M 43.98M 50.71M 44.15M 42.21M 40.02M 40.94M 43.14M
Adjusted Diluted Earnings per Share		 $35.21 $52.27 ($25.50) ($1.57) $15.31 $16.29 $4.91 ($6.15) $11.43 $9.28
Adjusted Weighted Average Diluted Shares Outstanding		 49.25M 52.69M 43.72M 43.98M 50.71M 44.15M 42.21M 40.02M 40.94M 43.14M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 49.25M 52.69M 43.72M 43.98M 50.71M 44.15M 42.21M 40.02M 40.94M 43.14M
Normalized Net Operating Profit after Tax (NOPAT)		 3,452 2,440 -660 69 1,199 752 309 -117 630 347
Normalized NOPAT Margin		 29.75% 26.92% -13.16% 1.31% 23.41% 20.16% 15.22% -5.69% 37.38% 23.50%
Pre Tax Income Margin		 25.80% 34.32% -24.32% -2.18% 19.44% 14.84% 12.95% -15.94% 37.40% 33.57%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 31.92 42.50 -25.22 -2.40 19.74 9.48 5.58 -7.43 14.96 13.69
NOPAT to Interest Expense		 31.57 49.47 -17.65 -1.68 19.68 9.19 5.71 -5.20 14.95 14.95
EBIT Less CapEx to Interest Expense		 31.92 42.50 -25.22 -2.40 19.74 9.48 5.58 -7.43 14.96 13.69
NOPAT Less CapEx to Interest Expense		 31.57 49.47 -17.65 -1.68 19.68 9.19 5.71 -5.20 14.95 14.95
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 3.93% 3.05% -8.63% -97.37% 10.01% 10.12% 30.84% -20.79% 11.74% 14.08%
Augmented Payout Ratio		 26.45% 3.05% -23.00% -1,090.70% 16.32% 10.12% 30.84% -73.97% 60.85% 62.01%

Quarterly Metrics And Ratios for RenaissanceRe

This table displays calculated financial ratios and metrics derived from RenaissanceRe's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 33.66% -30.09% 116.44% 52.63% 17.48% 57.53% 44.07% 116.73% 153.68% 94.73% -16.86%
EBITDA Growth		 -110.32% -105.37% 418.62% 110.83% -22.29% 111.09% 131.58% 222.30% 288.55% 1,656.45% -78.38%
EBIT Growth		 -111.17% -105.80% 307.37% 85.90% -27.08% 105.27% 135.90% 228.07% 300.19% 1,906.89% -79.04%
NOPAT Growth		 -108.01% -102.93% 291.97% 94.42% -26.40% 186.81% 150.17% 280.10% 376.47% 2,661.29% -79.04%
Net Income Growth		 -104.08% -100.97% 291.97% 94.42% -26.40% 186.81% 135.03% 240.50% 311.40% 140.51% -86.10%
EPS Growth		 -52.88% -111.95% 495.26% 130.07% -46.24% 202.60% 119.72% 154.32% 241.87% 121.28% -97.64%
Operating Cash Flow Growth		 -76.92% 51.99% 92.91% 534.83% 56.86% -30.10% 28.46% 89.19% 159.00% 69.35% 28.84%
Free Cash Flow Firm Growth		 83.57% 68.44% 34.89% 10.16% -2,565.38% -376.60% -1,230.49% -509.33% -17.59% 150.46% -57.65%
Invested Capital Growth		 4.85% 7.77% 29.48% 24.14% 52.14% 57.71% 47.41% 31.67% 4.90% -7.93% -10.34%
Revenue Q/Q Growth		 54.92% -44.06% 40.49% 9.79% -19.55% 73.16% -0.93% -15.49% 8.66% 58.36% 49.04%
EBITDA Q/Q Growth		 12.10% -103.89% 173.12% 10.44% -54.26% 275.85% 11.03% -59.29% 24.25% 156.23% -330.00%
EBIT Q/Q Growth		 14.85% -104.79% 145.09% 11.66% -55.81% 236.84% 11.85% -56.20% 24.39% 158.91% -299.00%
NOPAT Q/Q Growth		 14.85% -103.56% 124.08% 17.81% -68.90% 377.41% 11.14% -55.40% 21.20% 183.51% -299.00%
Net Income Q/Q Growth		 -31.42% -101.18% 124.08% 17.81% -68.90% 377.41% 11.14% -55.40% 21.20% 158.32% -345.73%
EPS Q/Q Growth		 186.97% -116.62% 140.38% 35.59% -77.95% 728.16% -7.09% -68.32% 24.13% 153.97% -155.91%
Operating Cash Flow Q/Q Growth		 -79.74% -47.73% 22.92% 77.38% 33.36% -33.65% 304.50% -56.17% -40.57% 21.93% 495.72%
Free Cash Flow Firm Q/Q Growth		 32.66% 52.05% -1.76% 50.01% -29.35% 1.05% -40.42% -1,471.71% -85.49% 304.42% -49.16%
Invested Capital Q/Q Growth		 3.85% -5.12% 7.24% -0.78% 6.75% 13.99% 2.81% 21.61% 10.66% 6.55% -8.17%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 -1.95% -3.43% 49.33% 25.37% 25.22% 44.69% 20.59% 18.37% 38.13% 33.35% -93.92%
EBIT Margin		 -2.06% -3.74% 43.65% 25.02% 24.60% 45.12% 23.19% 20.54% 39.64% 34.62% -93.07%
Profit (Net Income) Margin		 -0.73% -0.86% 41.09% 25.76% 24.01% 62.55% 22.69% 20.22% 38.32% 34.36% -93.29%
Tax Burden Percent		 35.69% 23.12% 94.12% 102.95% 97.57% 138.64% 97.82% 98.44% 96.67% 99.23% 100.24%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 5.88% -2.95% 2.43% -38.64% 2.18% 1.56% 3.33% 0.77% 0.00%
Return on Invested Capital (ROIC)		 -0.90% -1.61% 28.20% 15.44% 14.10% 38.17% 13.39% 10.88% 19.51% 14.32% -22.95%
ROIC Less NNEP Spread (ROIC-NNEP)		 -0.17% 0.06% 28.20% 15.44% 14.10% 38.17% 13.39% 10.88% 19.51% 14.32% -42.79%
Return on Net Nonoperating Assets (RNNOA)		 -0.03% 0.01% 4.71% 2.70% 2.50% 6.43% 2.67% 1.93% 3.30% 2.86% -8.03%
Return on Equity (ROE)		 -0.94% -1.60% 32.91% 18.14% 16.60% 44.60% 16.07% 12.81% 22.81% 17.19% -30.98%
Cash Return on Invested Capital (CROIC)		 6.92% 8.19% 1.46% 0.05% -20.22% -20.41% -20.95% -22.07% -4.16% 1.16% -1.07%
Operating Return on Assets (OROA)		 -0.49% -0.87% 11.71% 5.61% 5.21% 9.56% 4.77% 3.94% 6.87% 4.92% -10.80%
Return on Assets (ROA)		 -0.17% -0.20% 11.02% 5.77% 5.08% 13.25% 4.67% 3.88% 6.65% 4.88% -10.82%
Return on Common Equity (ROCE)		 -0.53% -0.90% 18.19% 9.86% 8.61% 23.30% 7.90% 6.44% 11.22% 8.96% -16.29%
Return on Equity Simple (ROE_SIMPLE)		 22.39% 0.00% 44.19% 36.86% 34.70% 0.00% 30.64% 9.72% 1.33% 0.00% -32.05%
Net Operating Profit after Tax (NOPAT)		 -50 -58 1,633 729 618 1,989 417 375 840 693 -830
NOPAT Margin		 -1.44% -2.62% 41.09% 25.76% 24.01% 62.55% 22.69% 20.22% 38.32% 34.36% -65.15%
Net Nonoperating Expense Percent (NNEP)		 -0.73% -1.67% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 19.84%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 102.06% 103.74% 56.35% 74.98% 75.40% 54.88% 76.81% 79.46% 60.36% 65.38% 193.07%
Earnings before Interest and Taxes (EBIT)		 -71 -83 1,735 708 634 1,434 426 381 869 699 -1,186
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -67 -76 1,960 718 650 1,421 378 340 836 673 -1,197
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.23 1.32 1.35 1.25 1.33 1.14 1.47 1.22 1.70 1.73 1.47
Price to Tangible Book Value (P/TBV)		 1.33 1.42 1.45 1.36 1.45 1.26 1.52 1.27 1.78 1.83 1.56
Price to Revenue (P/Rev)		 0.95 1.11 1.13 1.13 1.27 1.10 1.27 1.11 1.37 1.58 1.50
Price to Earnings (P/E)		 7.25 7.04 3.94 4.49 5.16 3.95 7.20 21.53 0.00 0.00 0.00
Dividend Yield		 0.65% 0.63% 0.57% 0.69% 0.65% 0.78% 0.77% 0.81% 0.75% 0.81% 1.06%
Earnings Yield		 13.80% 14.20% 25.41% 22.26% 19.38% 25.34% 13.89% 4.64% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.03 1.07 1.10 1.04 1.07 0.97 1.13 1.03 1.20 1.19 1.07
Enterprise Value to Revenue (EV/Rev)		 1.68 1.81 1.81 1.92 2.20 1.94 2.27 2.19 2.41 2.73 2.86
Enterprise Value to EBITDA (EV/EBITDA)		 8.26 6.46 4.80 6.32 7.44 5.90 8.07 24.58 448.82 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 9.15 7.02 5.05 6.25 7.22 5.65 7.57 21.05 180.41 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 9.04 7.10 4.59 5.33 6.11 4.85 7.73 22.30 195.66 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 5.75 5.05 5.85 6.29 9.61 9.19 8.43 8.18 8.15 8.54 8.85
Enterprise Value to Free Cash Flow (EV/FCFF)		 15.22 13.58 85.19 2,337.74 0.00 0.00 0.00 0.00 0.00 98.38 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.19 0.12 0.14 0.17 0.21 0.17 0.20 0.19 0.14 0.17 0.19
Long-Term Debt to Equity		 0.16 0.11 0.11 0.12 0.12 0.13 0.14 0.14 0.10 0.12 0.13
Financial Leverage		 0.20 0.14 0.17 0.17 0.18 0.17 0.20 0.18 0.17 0.20 0.19
Leverage Ratio		 3.16 3.01 2.99 3.14 3.27 3.37 3.44 3.30 3.43 3.52 3.61
Compound Leverage Factor		 3.16 3.01 2.99 3.14 3.27 3.37 3.44 3.30 3.43 3.52 3.61
Debt to Total Capital		 16.25% 10.40% 12.31% 14.22% 17.07% 14.42% 16.90% 15.67% 12.00% 14.44% 16.27%
Short-Term Debt to Total Capital		 2.71% 0.77% 2.94% 4.04% 7.36% 3.64% 5.09% 3.53% 3.05% 4.28% 5.45%
Long-Term Debt to Total Capital		 13.54% 9.63% 9.38% 10.18% 9.71% 10.78% 11.81% 12.14% 8.95% 10.16% 10.82%
Preferred Equity to Total Capital		 3.69% 3.83% 3.63% 3.90% 3.87% 4.13% 4.70% 4.84% 5.88% 6.51% 6.93%
Noncontrolling Interests to Total Capital		 32.88% 35.62% 33.23% 32.91% 32.46% 33.57% 35.51% 36.60% 42.01% 39.35% 38.60%
Common Equity to Total Capital		 47.18% 50.15% 50.82% 48.97% 46.60% 47.89% 42.89% 42.90% 40.11% 39.70% 38.20%
Debt to EBITDA		 1.30 0.63 0.54 0.86 1.19 0.88 1.21 3.72 45.03 -1.34 -0.90
Net Debt to EBITDA		 0.66 0.11 0.20 0.35 0.61 0.25 0.67 2.28 13.73 -0.38 -0.28
Long-Term Debt to EBITDA		 1.09 0.58 0.41 0.62 0.68 0.66 0.85 2.88 33.57 -0.94 -0.60
Debt to NOPAT		 1.43 0.69 0.51 0.73 0.97 0.72 1.16 3.38 19.63 -1.95 -1.29
Net Debt to NOPAT		 0.72 0.12 0.20 0.30 0.50 0.21 0.64 2.07 5.99 -0.55 -0.41
Long-Term Debt to NOPAT		 1.19 0.64 0.39 0.52 0.55 0.54 0.81 2.62 14.64 -1.37 -0.85
Noncontrolling Interest Sharing Ratio		 43.73% 44.03% 44.72% 45.66% 48.16% 47.75% 50.82% 49.76% 50.80% 47.85% 47.41%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -991 -1,471 -3,068 -3,015 -6,031 -4,663 -4,712 -3,356 245 1,686 417
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 -36.58 -20.82 0.00 0.00 -261.05 -76.38 0.00 0.00 20.16 136.12 34.45
Operating Cash Flow to Interest Expense		 5.82 11.02 0.00 0.00 29.58 8.40 0.00 0.00 35.91 59.21 49.69
Operating Cash Flow Less CapEx to Interest Expense		 5.82 11.02 0.00 0.00 29.58 8.40 0.00 0.00 35.91 59.21 49.69
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.24 0.23 0.27 0.22 0.21 0.21 0.21 0.19 0.17 0.14 0.12
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 20,344 19,589 20,646 19,253 19,403 18,176 15,945 15,509 12,753 11,525 10,817
Invested Capital Turnover		 0.63 0.61 0.69 0.60 0.59 0.61 0.59 0.54 0.51 0.42 0.35
Increase / (Decrease) in Invested Capital		 941 1,413 4,701 3,744 6,650 6,651 5,129 3,731 596 -992 -1,247
Enterprise Value (EV)		 20,933 21,012 22,788 20,016 20,759 17,559 17,972 16,048 15,253 13,693 11,535
Market Capitalization		 11,820 12,923 14,207 11,819 12,006 9,966 10,061 8,135 8,678 7,938 6,055
Book Value per Share		 $194.89 $189.14 $201.18 $178.31 $171.01 $170.11 $133.61 $151.44 $117.01 $104.69 $94.54
Tangible Book Value per Share		 $180.96 $175.59 $187.42 $164.36 $156.66 $154.96 $129.05 $146.08 $111.60 $99.25 $89.07
Total Capital		 20,344 19,589 20,646 19,253 19,403 18,176 15,945 15,509 12,753 11,525 10,817
Total Debt		 3,306 2,037 2,543 2,739 3,312 2,620 2,694 2,430 1,530 1,664 1,760
Total Long-Term Debt		 2,754 1,887 1,936 1,960 1,884 1,959 1,883 1,882 1,141 1,170 1,170
Net Debt		 1,673 361 970 1,111 1,706 743 1,499 1,486 467 470 556
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 -24 -39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 359
Net Nonoperating Obligations (NNO)		 3,306 2,037 2,543 2,739 3,312 2,620 2,694 2,430 1,530 1,664 1,760
Total Depreciation and Amortization (D&A)		 3.74 6.85 226 9.96 16 -14 -48 -40 -33 -26 -11
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $3.29 ($3.77) $22.68 $9.44 $6.96 $31.54 $3.81 $4.10 $12.95 $10.40 ($19.27)
Adjusted Weighted Average Basic Shares Outstanding		 48.65M 49.25M 51.94M 52.16M 52.88M 52.69M 51.17M 51.18M 43.93M 43.72M 43.70M
Adjusted Diluted Earnings per Share		 $3.27 ($3.76) $22.62 $9.41 $6.94 $31.47 $3.80 $4.09 $12.91 $10.40 ($19.27)
Adjusted Weighted Average Diluted Shares Outstanding		 48.65M 49.25M 51.94M 52.16M 52.88M 52.69M 51.17M 51.18M 43.93M 43.72M 43.70M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 48.65M 49.25M 51.94M 52.16M 52.88M 52.69M 51.17M 51.18M 43.93M 43.72M 43.70M
Normalized Net Operating Profit after Tax (NOPAT)		 21 52 1,751 571 722 1,098 497 454 915 764 -785
Normalized NOPAT Margin		 0.60% 2.33% 44.05% 20.19% 28.03% 34.54% 27.10% 24.50% 41.73% 37.88% -61.60%
Pre Tax Income Margin		 -2.06% -3.74% 43.65% 25.02% 24.60% 45.12% 23.19% 20.54% 39.64% 34.62% -93.07%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -2.61 -1.18 0.00 0.00 27.43 23.50 0.00 0.00 71.63 56.42 -98.02
NOPAT to Interest Expense		 -1.83 -0.82 0.00 0.00 26.77 32.57 0.00 0.00 69.25 55.99 -68.61
EBIT Less CapEx to Interest Expense		 -2.61 -1.18 0.00 0.00 27.43 23.50 0.00 0.00 71.63 56.42 -98.02
NOPAT Less CapEx to Interest Expense		 -1.83 -0.82 0.00 0.00 26.77 32.57 0.00 0.00 69.25 55.99 -68.61
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 4.97% 3.93% 2.34% 3.08% 3.36% 3.05% 4.59% 14.39% 128.86% -8.63% -6.37%
Augmented Payout Ratio		 49.20% 26.45% 6.67% 5.97% 3.36% 3.05% 4.59% 17.91% 128.86% -23.00% -37.67%

Frequently Asked Questions About RenaissanceRe's Financials

When does RenaissanceRe's financial year end?

According to the most recent income statement we have on file, RenaissanceRe's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has RenaissanceRe's net income changed over the last 9 years?

RenaissanceRe's net income appears to be on an upward trend, with a most recent value of $2.96 billion in 2024, rising from $542.24 million in 2015. The previous period was $3.62 billion in 2023. Find out what analysts predict for RenaissanceRe in the coming months.

How has RenaissanceRe revenue changed over the last 9 years?

Over the last 9 years, RenaissanceRe's total revenue changed from $1.48 billion in 2015 to $11.60 billion in 2024, a change of 684.5%.

How much debt does RenaissanceRe have?

RenaissanceRe's total liabilities were at $33.16 billion at the end of 2024, a 0.9% decrease from 2023, and a 473.9% increase since 2015.

How much cash does RenaissanceRe have?

In the past 9 years, RenaissanceRe's cash and equivalents has ranged from $421.16 million in 2016 to $1.88 billion in 2023, and is currently $1.68 billion as of their latest financial filing in 2024.

How has RenaissanceRe's book value per share changed over the last 9 years?

Over the last 9 years, RenaissanceRe's book value per share changed from 98.80 in 2015 to 189.14 in 2024, a change of 91.4%.


Related Companies

This page (NYSE:RNR) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
As Bitcoin supply vanishes, this Trump-aligned token could explode
Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...
Crypto 101 Media | Sponsored
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...
Brownstone Research | Sponsored